BAPRAS and BAAPS Scientific Meetings: Are we sticking our noses up at rhinoplasty?

Description to be added.Cannot be left empt

Additional file 1: of An assessment of the factors affecting the commercialization of cell-based therapeutics: a systematic review protocol

PRISMA-P (Preferred Reporting Items for Systematic review and Meta-Analysis Protocols) 2015 checklist: recommended items to address in a systematic review protocol*. (DOC 81 kb

Evidence of insufficient quality of reporting in patent landscapes in the life sciences

Despite the importance of patent landscape analyses in the commercialization process for life science and healthcare technologies, the quality of reporting for patent landscapes published in academic journals is inadequate

The Reporting Items for Patent Landscapes statement

The reporting quality of patent landscapes is inadequate. The Reporting Items for Patent Landscapes (RIPL) checklist can improve reporting quality